Press Room

16 Aug, 2010 10:26 CET

13 Aug, 2010 15:00 CET

Moberg Derma, nail fungus, onychomycosis, anti-fungal, dermatology, licensagreement, distribution, Emtrix, Perrigo

18 Jun, 2010 09:45 CET

Moberg Derma, nail fungus, nail, market, partner, OTC, dermatology, distribution, Emtrix

27 Apr, 2010 09:30 CET

Moberg Derma, dermatology, board, skin diseases

21 Apr, 2010 09:35 CET

Moberg Derma, nail fungus, onychomycosis, market, Canada, partner, dermatology, collaboration, licensagreement

12 Apr, 2010 09:32 CET

Moberg Derma, seborrheic dermatitis, seborrheic eczema, OTC, dermatology, ISO 13485, launch, skin diseases

12 Apr, 2010 09:31 CET

Moberg Derma, nail fungus, onychomycosis, nail, OTC, dermatology, launch, nail diseases, registration, skin diseases

22 Dec, 2009 10:48 CET

Moberg Derma

20 Nov, 2009 14:05 CET

Moberg Derma, K201, positive results, clinical trial, atopic eczema, phase II, dermatology, significant

18 Nov, 2009 13:30 CET

Moberg Derma, anti-fungal, dermatology, Vinnova, pharmaceutical, antifungals, grant, patent-protected

24 Aug, 2009 08:00 CET

Moberg Derma, nail fungus, onychomycosis, nail, phase III, positive results, anti-fungal, fungal, dermatology, investors, new share issue, shareholders

27 Feb, 2009 10:15 CET

Moberg Derma, K101, nail fungus, onychomycosis, partner, OTC, royalty, market organisation, commercial agreement, licens agreement, Nordic region

27 Feb, 2009 10:15 CET

Moberg Derma, royalty, MedPharm, Kaprolac, MedSpray, dermatology, collaboration, synergies, licensagreement, formulation technology, product development

27 Feb, 2009 10:15 CET

innovation, Moberg Derma, Zelmic, dermatology, collaboration, synergies, pharmaceutical projects, acquisition

9 Dec, 2008 11:30 CET

Moberg Derma, K101, K201, K301, nail fungus, phase III, atopic dermatitis, seborrheic dermatitis, Sales & Marketing, Sales and Marketing, recruits, sales organisation, commercial, market, phase II